Vol.53 No.4 April 2005

Evaluation of efficacy and safety of piperacillin for pneumonia and secondary infection with chronic respiratory disease

Shigeru Itabashi, Akira Watanabe, Mitsuo Kaku, Hiroaki Takeda, Katsunao Niitsuma, Kazuhiro Ozawa, Takashi Mouri, Kazutoshi Gomi, Yoshiyuki Nakai, Tatsuya Abe, Reiko Ono, Noboru Asou, Hiroshi Iga, Mitsunobu Homma, Hideki Ikeda, Sumito Inoue, Hiroshi Saito, Tomei Tsukamoto, Shunji Kaise, Shinsaku Maeda, Shuzo Suzuki, Yoshihiro Kazuta and Tatsuo Kawashima

Jpn. J. Chemother. 53 (4): 259-267, 2005

Development of reduced-size telithromycin tablet -Results of a bioequivalence study comparing reduced-size and currently available formulations-

Roza Ishihara, Koichi Enomoto, Kenichi Abe, Montay Guy and Shigeru Yakou

Jpn. J. Chemother. 53 (4): 268-273, 2005

Antichlamydial activity of telithromycin against Chlamydia trachomatis -Antichlamydial activity against fresh clinical isolates of C. trachomatis-

Ariaki Nagayama

Jpn. J. Chemother. 53 (4): 274-276, 2005

Annual survey of Helicobacter pylori susceptibility to clarithromycin and amoxicillin after approval of antibiotic eradication H. pylori

Intetsu Kobayashi, Takeshi Saika, Akiko Kanayama, Kaoru Matsuzaki, Miyuki Hasegawa and Yumie Sato

Jpn. J. Chemother. 53 (4): 277-279, 2005